# Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

> **NCT01500486** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 84 (actual)

## Conditions studied

- Growth Hormone Disorder
- Growth Hormone Deficiency in Children
- Delivery Systems

## Interventions

- **DEVICE:** NordiFlex PenMate™

## Key facts

- **NCT ID:** NCT01500486
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500486, "Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01500486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*